Acquisition of Molecular Profiles Limited (Tables)

12 Months Ended

Dec. 31, 2013

Business Combinations [Abstract]

Summary of Purchase Price Allocation, Net

The following table summarizes the purchase consideration paid for Molecular Profiles and the fair values of the assets acquired and liabilities assumed at the date of acquisition:

Purchase consideration:
Cash and stock paid	$	24,041,941
Cash acquired		(2,230,514	)
Debt assumed		3,889,486
Fair value of consideration transferred	$	25,700,913
Recognized amounts of identifiable assets acquired and liabilities assumed:
Accounts receivable	$	3,522,281
Prepaid expenses and other current assets		970,376
Property and equipment		11,967,176
Deferred tax assets		605,009
Identifiable intangible assets		2,910,000
Goodwill		10,660,296
Accounts payable		(999,539	)
Accrued expenses		(1,045,309	)
Deferred revenue		(2,889,377	)
Total	$	25,700,913

Unaudited Pro Forma Condensed Consolidated Operating Results

The following unaudited pro forma condensed consolidated operating results for the years ended December 31, 2013 and 2012 summarize the combined results of operations for Columbia and Molecular Profiles.  

	Year Ended December 31,
	2013		2012
Revenues	$	36,074,941	$	30,965,698
Pre-tax income	$	6,251,894	$	7,600,216
Basic net income per share	$	0.52	$	0.63
Diluted net income per share	$	0.45	$	0.05